FdaApplication

ANDA 217095

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTORRENT PHARMACEUTICALS LTD
application_typeANDA
approval_date2023-04-12

Products (1)

ProductActive ingredientStrengthDosage form
SORAFENIB TOSYLATESORAFENIB TOSYLATEEQ 200MG BASETABLET;ORAL

1 product